VisionWave Holdings, Inc. is a defense and advanced sensing technology company developing AI-driven, radio-frequency (RF)-based sensing, autonomy, and computational acceleration technologies for defense, homeland security, and commercial infrastructure applications. Headquartered in Wilmington, Delaware, the company focuses on radars, vision systems, and RF sensing, integrating artificial intelligence and autonomous solutions across air, ground, and sea domains. Investors follow VWAV for exposure to defense-AI and counter-drone themes, but the micro-cap's capital structure and ongoing financing needs have made the stock exceptionally volatile.
Over the trailing 30 days, VWAV has declined roughly 76%, falling from approximately $4.39 to about $1.04 on a split-adjusted basis. Intraday trading has periodically pushed the price even lower, underscoring persistent selling pressure rather than a single-day dislocation. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The last quarter tells a similar story on a larger scale. The stock entered September trading near $9.70 (split-adjusted) and has since lost roughly 89% of its value. The decline has been broad and sustained, driven primarily by capital-structure concerns and repeated share issuance rather than a fundamental change in the company's defense technology business.
The dominant catalyst has been dilution. VisionWave has relied on convertible financing through a securities purchase agreement and related notes and debentures, and it announced a $30 million at-the-market equity sales agreement with Aegis Capital. Convertible instruments and ongoing share issuance have steadily increased the effective share count and weighed on the stock.
Capital-structure proposals added to the pressure. A special meeting of stockholders scheduled for November 19, 2026, seeks approval to raise authorized common shares from 150 million to 2 billion and to authorize additional reverse splits ranging from 1-for-2 to 1-for-1,000. The company also proposed authorizing offerings of up to $40 million and up to 760 million shares. The board has warned that these measures could substantially dilute existing stockholders, and management has indicated that cash resources may be insufficient to repay obligations as they come due. Nasdaq minimum-bid compliance concerns have compounded investor unease.
The broader multi-month decline has been shaped by the same financing overhang. On September 22, 2026, the company completed a 1-for-20 reverse stock split designed to lift the per-share price above Nasdaq's $1.00 minimum-bid requirement. While the split briefly raised the nominal share price, continued conversions and equity sales quickly reasserted downward pressure.
Positive-sounding developments, including a U.S. non-provisional patent application for the ARGUS space-enabled, AI-driven counter-drone architecture and an invitation from Liberia's regulator to enter production-sharing contract negotiations, generated short-lived sentiment spikes. Those headlines were repeatedly overshadowed by dilution concerns, and the stock's quarterly trend remained sharply negative.
Looking ahead, investors should monitor the outcome of the November 19, 2026, special meeting and any resulting share-issuance activity, as these decisions will directly affect the share count and dilution outlook. Nasdaq listing compliance, the company's ability to meet its financing obligations, and its cash runway into 2027 are additional factors that could shape the stock's trajectory.
On the operating side, progress on defense contracts and counter-drone initiatives, including any commercialization of the ARGUS architecture, will be relevant. Because VWAV is a thinly traded micro-cap with a heavy financing overhang, volatility is likely to remain elevated regardless of company-specific announcements.
In my view, automated tools can help cut through the noise in volatile names like this one. I regularly turn to Tickeron’s AI Trading Bots to test different strategies against similar micro-cap defense stocks and see how they might align with my own risk parameters. The platform offers a range of options across timeframes and approaches, which I find useful when evaluating whether to adjust exposure during periods of heavy dilution pressure. It is not a substitute for fundamental review, but it adds another layer of context to the decision process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where VWAV declined for three days, in 98 of 103 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VWAV as a result. In 15 of 18 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The Aroon Indicator for VWAV entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +17.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where VWAV advanced for three days, in 36 of 48 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.025) is normal, around the industry mean (5.050). P/E Ratio (-1.035) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. VWAV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VWAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense